Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Signals in the Noise: Biomarkers in Rheumatoid Arthritis
-
- Scleroderma and Collagen Vascular Disorders
- Five Important News Items from the EULAR Annual Congress
- Alliance for Health Reform Hosts National Policy Briefing on Biosimilars Market
- Phase 3 Study Shows Positive Results With Tocilizumab for Giant Cell Arteritis
- Sandoz Plans to Launch Five Major Global Biosimilars by 2020
- Biomarkers Signal the Next Horizon in Rheumatology
- The Patient With Spondyloarthritis
- Rituximab Decreased Disease Activity in Patients with Severe or Refractory SLE
-
- Study Links Coexisting Fibromyalgia to Poorer Test Scores in Patients With PsA
- Baricitinib Inhibits Progressive Radiographic Joint Damage in Rheumatoid Arthritis
- CHS-0214 Biosimilar Shows Equivalence in Efficacy to Etanercept
- Depression Linked to More Inflamed Joints, Disability in Adolescent Patients With JIA
- Early Use of Subcutaneous Methotrexate May Delay Need for Biologic DMARDs
- Obesity, Smoking Linked WIth Reduced Likelihood of Sustained Remission in Patients With Early RA
- Study Links Childhood Appendicitis to lower Risk for Developing Ankylosing Spondylitis
- VIDEO: Khanna Discusses Safety, Efficacy of Tocilizumab for Systemic Sclerosis
-
- CDC Reports Increas in Physician-Diagnosed Arthritis in United States
- Survey: Patients Believe Gout Can Be Successfully Managed With Dietary Changes Alone